Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : Antiparkinsonian or Classic Psychedelic or Neuroactive steroid

Use the filters below to narrow your results.

generic:
None (2)
brand:
None (70) · Akineton (1) · Apokyn (1) · Artane (1) · Azilect (1) · Cogentin (1) · Comtan (1) · Delysid (historical, Sandoz, withdrawn 1965) (1) · Dostinex (1) · Eldepryl (1) · Neupro (1) · Ongentys (1) · Parlodel (1) · Sinemet (1) · Symmetrel (1) · Tasmar (1) · Xadago (1) · Zulresso (1) · Zurzuvae (1)
classes: (Click arrow to add another value)
mechanism:
5-HT2A agonist (26) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · Contains LSA (2) · Contains mescaline (2) · Irreversible selective MAO-B inhibitor (2)
uses:
None (86) · Postpartum depression (PPD) in adults (1) · Postpartum depression (PPD) in adults (FDA-approved 2023) (1)
starting dose:
None (86) · 50 mg PO once daily with fatty food in the evening × 14 days (1) · Single 60-hour continuous IV infusion: 30 mcg/kg/h × 4h → 60 mcg/kg/h × 20h → 90 mcg/kg/h × 28h → 60 mcg/kg/h × 4h → 30 mcg/kg/h × 4h (1)
preparations:
None (86) · 100 mg/20 mL vial, single-use (1) · 20 mg, 25 mg, 30 mg capsules (1)
fda max:
None (86) · 50 mg/d × 14 d (1) · Single 60-hour course (1)
routes:
None (85) · Intravenous (continuous infusion in a REMS-certified facility) (1) · Oral (2)
onset:
None (85) · 30–60 minutes (1) · Antidepressant effect within hours of infusion start; sustained at 30 days (1) · Day 3 of dosing in trials; sustained through day 45 (1)
duration:
None (85) · 14-day course; effect persists after discontinuation in trials (1) · 8–12 hours (1) · Single infusion course (1)
halflife:
None (85) · 3–5 hours (1) · ~16-23 hours (1) · ~9 hours (terminal) (1)
bioavailability:
None (85) · 100% (IV) (1) · 70–90% (oral) (1) · Adequate (food-dependent, must take with fatty meal) (1)
pregnancy:
None (85) · Limited data; avoid in pregnancy. Lactation: present in milk; consider risks (1) · Medicine is structurally identical to endogenous allopregnanolone; pregnancy considerations relate to breastfeeding during/after infusion. Limited data; brief interruption of breastfeeding considered (1) · Not established (1)
legal:
None (85) · Rx, Schedule IV (US) (1) · Rx; REMS program required (excessive sedation/loss of consciousness during infusion) (1) · Schedule I (United States) (1)

Showing below up to 88 results in range #1 to #88.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"